Folic Acid Supplementation in Calcific Aortic Valve Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT05861648
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT05861648
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05861648. Randomized; double masking; primary purpose prevention. Start 2023-07-01 (anticipated); primary completion 2025-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Folic Acid Supplementation in Calcific Aortic Valve Disease
- Condition
- Calcification of Aortic Valve
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- Folic Acid Oral Tablet
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Record details
- Record id
cardio:ct-nct05861648- Content hash
e745414fed2823e1fd97a258a3f1aced8532cc8a34f019dcdd50592796fa1f1a